Published in Immunopharmacol Immunotoxicol on February 01, 1998
The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms. Cancer Manag Res (2012) 0.81
Immunomodulatory activity of interferon-beta. Ann Clin Transl Neurol (2014) 0.80
Dynamic proteomics of individual cancer cells in response to a drug. Science (2008) 5.43
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
Efficient sampling algorithm for estimating subgraph concentrations and detecting network motifs. Bioinformatics (2004) 3.25
Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2007) 3.12
Subgraphs in random networks. Phys Rev E Stat Nonlin Soft Matter Phys (2003) 2.65
Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology (2011) 2.47
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate. Mult Scler (2010) 2.30
Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology (2010) 2.29
The cost of delaying treatment in multiple sclerosis: what is lost is not regained. Neurology (2001) 2.27
Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. Lab Invest (1976) 1.96
Topological generalizations of network motifs. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 1.78
Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest (1993) 1.62
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions. Lab Invest (1976) 1.42
Prognosis of ocular myasthenia. Ann Neurol (1983) 1.35
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol (1997) 1.22
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis. Mult Scler (2008) 1.13
Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor. Neurology (1982) 1.13
Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein. Proc Natl Acad Sci U S A (1992) 1.11
Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases. Ann Rheum Dis (2000) 1.09
Neurological features of West Nile virus infection during the 2000 outbreak in a regional hospital in Israel. J Neurol Sci (2002) 1.01
The rodent malaria parasite Plasmodium yoelii lacks both types 1 and 2 T-independent antigens. J Immunol (1982) 0.99
A preliminary trial of poly(I,C)-LC in multiple sclerosis. J Biol Response Mod (1985) 0.99
Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial. Neurology (1996) 0.98
Delayed epidural hematoma. A review. Acta Neurochir (Wien) (1987) 0.95
Pathogenesis of visna. III. Immune responses to central nervous system antigens in experimental allergic encephalomyelitis and visna. Lab Invest (1976) 0.95
Use of the peripheral dopamine antagonist, domperidone, in the management of gastro-intestinal symptoms in patients with irritable bowel syndrome. Curr Med Res Opin (1980) 0.92
Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases. Ann Neurol (1983) 0.91
Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristics. Neurology (1986) 0.89
Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis. Mult Scler (2002) 0.88
Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells. J Neuroimmunol (1995) 0.87
"Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. J Clin Gastroenterol (1991) 0.87
Glatiramer acetate blocks the activation of THP-1 cells by interferon-gamma. Eur J Pharmacol (1998) 0.86
Additive effects of copolymer-1 and interferon beta-1b on the immune response to myelin basic protein. J Neuroimmunol (1995) 0.86
Pepper-spray-induced respiratory failure treated with extracorporeal membrane oxygenation. Pediatrics (1996) 0.86
Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology (1996) 0.86
Immunological studies of scrapie infection. J Neuroimmunol (1982) 0.86
Spontaneous diabetes in eSS rats. Acta Diabetol Lat (1989) 0.85
The ultrastructure of early visna lesions. Acta Neuropathol (1977) 0.85
Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis. J Neuroimmunol (2005) 0.85
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS. J Neurol (2008) 0.83
Clinical trials of interferons in multiple sclerosis. What have we learned? J Neuroimmunol (1993) 0.83
High prevalence of malignant melanoma in Israeli patients with Parkinson's disease. J Neural Transm (Vienna) (2011) 0.81
Congenital enzymopenic methaemoglobinaemia. Clinical and biochemical study of a family with three homozygotes. Acta Haematol (1976) 0.81
Stroke in the very elderly: characteristics and outcome in patients aged ≥85 years with a first-ever ischemic stroke. Neuroepidemiology (2012) 0.81
Induction of RANTES chemokine expression in human astrocytic cells is dependent upon activation of NF-kappaB transcription factor. Int J Mol Med (2001) 0.80
Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein. Ann Neurol (1981) 0.79
Effect of sinus surgery on pulmonary function in patients with cystic fibrosis. Laryngoscope (1997) 0.79
Effects of IFN-beta on human cerebral blood flow distribution. J Interferon Cytokine Res (1998) 0.79
Epidural metastasis by Wilms' tumor. Am J Dis Child (1981) 0.79
Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cells. Brain Res Mol Brain Res (2001) 0.79
Descending perineum syndrome: control defecogram with a "perineum device", perspective in prevention and conservative therapy. J Belge Radiol (1988) 0.79
A comparison of interferon responses to poly ICLC in males and females. J Interferon Res (1985) 0.79
Preliminary trial of poly ICLC in chronic progressive multiple sclerosis. Neurology (1986) 0.78
Endotoxin induces increased intracellular cathepsin B activity in THP-1 cells. Immunopharmacol Immunotoxicol (1997) 0.78
Modulation of interferon gamma induced increases in cathepsin B in THP-1 cells by adrenergic agonists and antagonists. Cell Biol Int (1998) 0.78
Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury? Neurology (1999) 0.77
Intramedullary spinal cord abscess in a healthy woman. Neurology (2007) 0.77
Glatiramer acetate inhibition of tumor necrosis factor-alpha-induced RANTES expression and release from U-251 MG human astrocytic cells. J Neurochem (2001) 0.77
Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase. Clin Chim Acta (1986) 0.77
Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription. Neurochem Res (2001) 0.77
Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression? Mult Scler (2009) 0.77
Mechanisms underlying the synergistic effect of Th1 cytokines on RANTES chemokine production by human glial cells. Int J Mol Med (2001) 0.77
Tiapride as treatment for certain patients with idiopathic torsion dystonia. Eur Neurol (1991) 0.75
Inactivation gating and 4-AP sensitivity in human brain Kv1.4 potassium channel. Brain Res (1999) 0.75
Bilateral vestibular failure as a unique presenting sign in carcinomatous meningitis: case report. J Neurol Neurosurg Psychiatry (2001) 0.75
Effect of protein kinase modulators on the regulation of cathepsin B activity in THP-1 human monocytic leukemia cells. Oncol Rep (1998) 0.75
Tracheobronchography in children. Laryngoscope (1996) 0.75
Interferon-gamma induced increases in intracellular cathepsin B activity in THP-1 cells are dependent on RNA transcription. J Neuroimmunol (1997) 0.75
Comparison of RANTES chemokine induction by Th1 cytokines in human astroglial cell lines. Int J Mol Med (2001) 0.75
Truncal vagotomy and pyloroplasty for gastric and duodenal ulcer. Ten years' experience. Acta Gastroenterol Belg (1976) 0.75
[Interferons in multiple sclerosis]. Harefuah (1994) 0.75
Purulent meningitis due to Pseudomonas aeruginosa successfully treated with colistin and piperacillin. J Infect (1985) 0.75
Amitriptyline for intractable hiccup. Am J Gastroenterol (1988) 0.75
Liver enzyme abnormalities after poly ICLC infusions. Cancer Treat Rep (1985) 0.75
Proteinases in inflammatory demyelinating disease. Springer Semin Immunopathol (1985) 0.75
Augmented anti-acetylcholine receptor response following long-term penicillamine administration. Ann Neurol (1984) 0.75
Oligoclonal bands in meningeal carcinomatosis. Arch Neurol (1983) 0.75
[Goiter in the posterior mediastinum]. Acta Clin Belg (1976) 0.75
CSF fistula and tension pneumatocele 22 years after head injury. Neurochirurgia (Stuttg) (1988) 0.75
Gamma interferon induced increases in intracellular cathepsin B activity in PMA primed THP-1 cells are blocked by inhibitors of protein kinase C. Immunopharmacol Immunotoxicol (1996) 0.75
On fuzzy correlations. IEEE Trans Syst Man Cybern B Cybern (2001) 0.75
Analysis of 3,4-diaminopyridine in human serum by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection. J Chromatogr (1989) 0.75
[Localization of immunoglobulins and incorporation of uridine 3 h in the bursal follicles in chickens]. Riv Istochim Norm Patol (1974) 0.75
Gastrointestinal bleeding revealing a minor form of haemophilia A in an elderly patient. Tijdschr Gastroenterol (1973) 0.75
Pathogenesis of visna: review and speculation. Front Biol (1976) 0.75